ELIA GROUP SA/NV (ELI.BR) Fundamental Analysis & Valuation

EBR:ELI • BE0003822393

Current stock price

140.3 EUR
+0.4 (+0.29%)
Last:

This ELI.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ELI.BR Profitability Analysis

1.1 Basic Checks

  • ELI had positive earnings in the past year.
  • ELI had a positive operating cash flow in the past year.
  • Each year in the past 5 years ELI has been profitable.
  • Of the past 5 years ELI 4 years had a positive operating cash flow.
ELI.BR Yearly Net Income VS EBIT VS OCF VS FCFELI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

1.2 Ratios

  • ELI's Return On Assets of 1.73% is on the low side compared to the rest of the industry. ELI is outperformed by 85.00% of its industry peers.
  • The Return On Equity of ELI (6.83%) is worse than 80.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.81%, ELI is doing worse than 85.00% of the companies in the same industry.
  • ELI had an Average Return On Invested Capital over the past 3 years of 3.12%. This is below the industry average of 7.53%.
Industry RankSector Rank
ROA 1.73%
ROE 6.83%
ROIC 2.81%
ROA(3y)1.7%
ROA(5y)1.66%
ROE(3y)6.93%
ROE(5y)6.66%
ROIC(3y)3.12%
ROIC(5y)3.03%
ELI.BR Yearly ROA, ROE, ROICELI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • The Profit Margin of ELI (12.53%) is better than 75.00% of its industry peers.
  • In the last couple of years the Profit Margin of ELI has grown nicely.
  • ELI's Operating Margin of 23.30% is fine compared to the rest of the industry. ELI outperforms 75.00% of its industry peers.
  • ELI's Operating Margin has been stable in the last couple of years.
  • Looking at the Gross Margin, with a value of 65.27%, ELI is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • ELI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.3%
PM (TTM) 12.53%
GM 65.27%
OM growth 3Y17.22%
OM growth 5Y-0.29%
PM growth 3Y9.86%
PM growth 5Y2.05%
GM growth 3Y29.03%
GM growth 5Y4.73%
ELI.BR Yearly Profit, Operating, Gross MarginsELI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

2

2. ELI.BR Health Analysis

2.1 Basic Checks

  • ELI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ELI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ELI has more shares outstanding
  • ELI has a better debt/assets ratio than last year.
ELI.BR Yearly Shares OutstandingELI.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ELI.BR Yearly Total Debt VS Total AssetsELI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 0.79, we must say that ELI is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ELI (0.79) is worse than 85.00% of its industry peers.
  • ELI has a Debt/Equity ratio of 2.07. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.07, ELI is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.07
Debt/FCF N/A
Altman-Z 0.79
ROIC/WACC0.56
WACC4.99%
ELI.BR Yearly LT Debt VS Equity VS FCFELI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.22 indicates that ELI should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.22, ELI is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • ELI has a Quick Ratio of 1.14. This is a normal value and indicates that ELI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ELI (1.14) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.14
ELI.BR Yearly Current Assets VS Current LiabilitesELI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

6

3. ELI.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.60% over the past year.
  • The Earnings Per Share has been growing by 8.71% on average over the past years. This is quite good.
  • ELI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.92%.
  • The Revenue has been growing by 14.99% on average over the past years. This is quite good.
EPS 1Y (TTM)5.6%
EPS 3Y6.56%
EPS 5Y8.71%
EPS Q2Q%-9.07%
Revenue 1Y (TTM)17.92%
Revenue growth 3Y7.1%
Revenue growth 5Y14.99%
Sales Q2Q%-0.39%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.90% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 11.33% on average over the next years. This is quite good.
EPS Next Y21.02%
EPS Next 2Y16.32%
EPS Next 3Y15.53%
EPS Next 5Y16.9%
Revenue Next Year13.19%
Revenue Next 2Y15.9%
Revenue Next 3Y17.1%
Revenue Next 5Y11.33%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ELI.BR Yearly Revenue VS EstimatesELI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
ELI.BR Yearly EPS VS EstimatesELI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

1

4. ELI.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • ELI is valuated quite expensively with a Price/Earnings ratio of 25.23.
  • Based on the Price/Earnings ratio, ELI is valued a bit more expensive than 75.00% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ELI to the average of the S&P500 Index (27.42), we can say ELI is valued inline with the index average.
  • A Price/Forward Earnings ratio of 22.15 indicates a rather expensive valuation of ELI.
  • Based on the Price/Forward Earnings ratio, ELI is valued a bit more expensive than 75.00% of the companies in the same industry.
  • ELI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.29.
Industry RankSector Rank
PE 25.23
Fwd PE 22.15
ELI.BR Price Earnings VS Forward Price EarningsELI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ELI indicates a slightly more expensive valuation: ELI is more expensive than 70.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.24
ELI.BR Per share dataELI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

  • ELI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ELI's earnings are expected to grow with 15.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.2
PEG (5Y)2.9
EPS Next 2Y16.32%
EPS Next 3Y15.53%

2

5. ELI.BR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.03%, ELI has a reasonable but not impressive dividend return.
  • With a Dividend Yield of 1.03, ELI pays less dividend than the industry average, which is at 3.11. 80.00% of the companies listed in the same industry pay a better dividend than ELI!
  • Compared to an average S&P500 Dividend Yield of 1.81, ELI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.03%

5.2 History

  • The dividend of ELI decreases each year by -3.82%.
Dividend Growth(5Y)-3.82%
Div Incr Years6
Div Non Decr Years6
ELI.BR Yearly Dividends per shareELI.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • 23.21% of the earnings are spent on dividend by ELI. This is a low number and sustainable payout ratio.
DP23.21%
EPS Next 2Y16.32%
EPS Next 3Y15.53%
ELI.BR Yearly Income VS Free CF VS DividendELI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B
ELI.BR Dividend Payout.ELI.BR Dividend Payout, showing the Payout Ratio.ELI.BR Dividend Payout.PayoutRetained Earnings

ELI.BR Fundamentals: All Metrics, Ratios and Statistics

ELIA GROUP SA/NV

EBR:ELI (4/27/2026, 2:13:18 PM)

140.3

+0.4 (+0.29%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)03-05
Earnings (Next)05-20
Inst Owners27.31%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap15.30B
Revenue(TTM)4.44B
Net Income(TTM)556.60M
Analysts83.16
Price Target146.23 (4.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.03%
Yearly Dividend1.38
Dividend Growth(5Y)-3.82%
DP23.21%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.95%
PT rev (3m)21.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.89%
EPS NY rev (3m)6.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-6.07%
Revenue NY rev (3m)-6.01%
Valuation
Industry RankSector Rank
PE 25.23
Fwd PE 22.15
P/S 3.44
P/FCF N/A
P/OCF 7.32
P/B 1.88
P/tB 3.07
EV/EBITDA 16.24
EPS(TTM)5.56
EY3.96%
EPS(NY)6.33
Fwd EY4.51%
FCF(TTM)-27.05
FCFYN/A
OCF(TTM)19.17
OCFY13.66%
SpS40.73
BVpS74.72
TBVpS45.66
PEG (NY)1.2
PEG (5Y)2.9
Graham Number96.6852 (-31.09%)
Profitability
Industry RankSector Rank
ROA 1.73%
ROE 6.83%
ROCE 3.79%
ROIC 2.81%
ROICexc 3.31%
ROICexgc 3.84%
OM 23.3%
PM (TTM) 12.53%
GM 65.27%
FCFM N/A
ROA(3y)1.7%
ROA(5y)1.66%
ROE(3y)6.93%
ROE(5y)6.66%
ROIC(3y)3.12%
ROIC(5y)3.03%
ROICexc(3y)3.52%
ROICexc(5y)3.72%
ROICexgc(3y)4.2%
ROICexgc(5y)4.69%
ROCE(3y)4.22%
ROCE(5y)4.09%
ROICexgc growth 3Y-10.14%
ROICexgc growth 5Y-1.74%
ROICexc growth 3Y-5.25%
ROICexc growth 5Y0.12%
OM growth 3Y17.22%
OM growth 5Y-0.29%
PM growth 3Y9.86%
PM growth 5Y2.05%
GM growth 3Y29.03%
GM growth 5Y4.73%
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 2.07
Debt/FCF N/A
Debt/EBITDA 9.52
Cap/Depr 679.71%
Cap/Sales 113.47%
Interest Coverage 2.41
Cash Conversion 117.67%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.14
Altman-Z 0.79
F-Score7
WACC4.99%
ROIC/WACC0.56
Cap/Depr(3y)616.86%
Cap/Depr(5y)483.49%
Cap/Sales(3y)99.27%
Cap/Sales(5y)77.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.6%
EPS 3Y6.56%
EPS 5Y8.71%
EPS Q2Q%-9.07%
EPS Next Y21.02%
EPS Next 2Y16.32%
EPS Next 3Y15.53%
EPS Next 5Y16.9%
Revenue 1Y (TTM)17.92%
Revenue growth 3Y7.1%
Revenue growth 5Y14.99%
Sales Q2Q%-0.39%
Revenue Next Year13.19%
Revenue Next 2Y15.9%
Revenue Next 3Y17.1%
Revenue Next 5Y11.33%
EBIT growth 1Y17.96%
EBIT growth 3Y25.54%
EBIT growth 5Y14.66%
EBIT Next Year105.64%
EBIT Next 3Y44.55%
EBIT Next 5Y32.79%
FCF growth 1Y20.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y121.39%
OCF growth 3Y13.46%
OCF growth 5YN/A

ELIA GROUP SA/NV / ELI.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ELIA GROUP SA/NV?

ChartMill assigns a fundamental rating of 4 / 10 to ELI.BR.


What is the valuation status of ELIA GROUP SA/NV (ELI.BR) stock?

ChartMill assigns a valuation rating of 1 / 10 to ELIA GROUP SA/NV (ELI.BR). This can be considered as Overvalued.


Can you provide the profitability details for ELIA GROUP SA/NV?

ELIA GROUP SA/NV (ELI.BR) has a profitability rating of 5 / 10.


What is the financial health of ELIA GROUP SA/NV (ELI.BR) stock?

The financial health rating of ELIA GROUP SA/NV (ELI.BR) is 2 / 10.


What is the expected EPS growth for ELIA GROUP SA/NV (ELI.BR) stock?

The Earnings per Share (EPS) of ELIA GROUP SA/NV (ELI.BR) is expected to grow by 21.02% in the next year.